RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the previous year's EUR 833.5 million. EBITDA rose to EUR 57.0 million from EUR 46.7 million, and consolidated profit increased to EUR 22.5 million from EUR 14.7 million. The company treated 513,700 patients during the period, a 9% increase compared to 471,295 in the same period last year.
The results were significantly impacted by immediate transformation costs established to offset higher personnel and material costs from previous years. Despite these costs, the company continues to invest in expanding regional health networks and improving medical technology across its sites. Notably, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have formed a strategic partnership to enhance lung patient care. In Brandenburg, the newly opened child protection emergency service at the Frankfurt (Oder) site has created a strong regional network with cooperation agreements involving the hospital, the city, and the district.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks for the future healthcare system, stating that rigid sectoral boundaries hinder patient care and increase costs. He stressed that collaboration among general practitioners, specialists, and other providers is essential to ensure comprehensive care, especially in rural areas.
Dr. Stefan Stranz, also on the Board, criticized the Statutory Health Insurance Contribution Rate Stabilization Act for imposing further burdens on hospitals. He argued that instead of reducing bureaucracy, the reform adds more documentation requirements, budget cuts, and financial risks to already overburdened hospitals.
For the full year 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion (plus or minus 5%) and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates moderate improvements in non-financial indicators such as number of cases and cost weights.
However, the forecast is subject to considerable uncertainties due to ongoing legislative changes, including the Hospital Reform Adjustment Act (KHAG) effective April 15, 2026, and the GKV Contribution Rate Stabilisation Act (GKV-BStabG) adopted on July 10, 2026. These reforms aim to enhance quality and efficiency but are expected to increase financial pressure on hospitals in the short term. Global crises and economic volatility also contribute to higher prices and supply bottlenecks, adding to the uncertainty.
The company's interim report for the first half of 2026 is published on its website.
